Industry News, Sleep-Disordered Breathing

Ognomy Sleep Raises $20M Series A to Expand AI-Enabled Sleep Apnea Care

Ognomy Sleep, announced the closing of a $20 million Series A financing round led by Catalyst Investors, with participation from Blue Heron Capital. The round also included new and follow-on investments from Impellent Ventures, LaunchNY, Excell and Upstate Biotech Ventures, University of Buffalo, and strategic partners who have supported the company’s […]

Obstructive Sleep Apnea, Product/Vendor Updates

LivaNova Shares Positive 12-Month Results From Obstructive Sleep Apnea Study

Recently published study results demonstrate the efficacy of LivaNova Plc’s aura6000 System in treating moderate to severe obstructive sleep apnea (OSA). Published in Annals of Internal Medicine, the full 12-month results from the company’s OSPREY randomized controlled trial (RCT) demonstrate the safety and efficacy of proximal hypoglossal nerve stimulation (pHGNS), a differentiated neurostimulation modality. Overall, the study authors concluded that pHGNS for OSA yielded clinically significant improvements versus […]

Patient Care

The Rise of Sleep APPs

Sleep medicine is at a critical point. Demand is rising, the science is expanding, and too few specialists are available to meet the need. The U.S. has just 7,500 board-certified sleep specialists to serve a population of 325 million—many of whom have sleep disorders with complex comorbidities that require ongoing, […]

Research/Studies

Monash University and Brigham and Women’s Hospital to Advance Innovation in Sleep and Circadian Medicine

Monash University and Brigham and Women’s Hospital (BWH) today announce the renewal of their landmark research partnership at a ceremony in Boston, Massachusetts.  Australia’s largest university and one of Boston’s largest hospitals are advancing innovation in sleep and circadian medicine through a world-leading research initiative that will include investigating the […]